Liu J, Xue Y, Bai K, Yan F, Long X, Guo H
Front Pharmacol. 2024; 15:1380304.
PMID: 38783957
PMC: 11113551.
DOI: 10.3389/fphar.2024.1380304.
Martino J, Arcieri M, Madeddu F, Pieroni M, Carotenuto G, Bottoni P
Int J Mol Sci. 2024; 25(1).
PMID: 38203410
PMC: 10778928.
DOI: 10.3390/ijms25010234.
Pieroni M, Madeddu F, Martino J, Arcieri M, Parisi V, Bottoni P
Int J Mol Sci. 2023; 24(14).
PMID: 37511429
PMC: 10380688.
DOI: 10.3390/ijms241411671.
Madeddu F, Martino J, Pieroni M, Del Buono D, Bottoni P, Botta L
Int J Mol Sci. 2022; 23(23).
PMID: 36498979
PMC: 9737192.
DOI: 10.3390/ijms232314652.
Huang N, Lin J
Nucleic Acids Res. 2015; 43(14):6772-86.
PMID: 26150421
PMC: 4538842.
DOI: 10.1093/nar/gkv672.
Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.
Arno B, DAnnessa I, Tesauro C, Zuccaro L, Ottaviani A, Knudsen B
PLoS One. 2013; 8(7):e68404.
PMID: 23844196
PMC: 3699648.
DOI: 10.1371/journal.pone.0068404.
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant.
Fiorani P, Tesauro C, Mancini G, Chillemi G, DAnnessa I, Graziani G
Nucleic Acids Res. 2009; 37(20):6849-58.
PMID: 19767617
PMC: 2777420.
DOI: 10.1093/nar/gkp669.
The open state of human topoisomerase I as probed by molecular dynamics simulation.
Chillemi G, Bruselles A, Fiorani P, Bueno S, Desideri A
Nucleic Acids Res. 2007; 35(9):3032-8.
PMID: 17439970
PMC: 1888835.
DOI: 10.1093/nar/gkm199.
Human topoisomerase I C-terminal domain fragment containing the active site tyrosine is a molten globule: implication for the formation of competent productive complex.
Punchihewa C, Dai J, Carver M, Yang D
J Struct Biol. 2007; 159(1):111-21.
PMID: 17434318
PMC: 1993844.
DOI: 10.1016/j.jsb.2007.03.001.
The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant.
Fiorani P, Chillemi G, Losasso C, Castelli S, Desideri A
Nucleic Acids Res. 2006; 34(18):5093-100.
PMID: 16990249
PMC: 1636438.
DOI: 10.1093/nar/gkl670.
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation.
Sari L, Andricioaei I
Nucleic Acids Res. 2005; 33(20):6621-34.
PMID: 16314322
PMC: 1298917.
DOI: 10.1093/nar/gki935.
Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model.
Kettmann V, Kostalova D, Holtje H
J Comput Aided Mol Des. 2005; 18(12):785-96.
PMID: 16075310
DOI: 10.1007/s10822-004-7878-1.
Molecular dynamics studies on free and bound targets of the bovine papillomavirus type I e2 protein: the protein binding effect on DNA and the recognition mechanism.
Djuranovic D, Hartmann B
Biophys J. 2005; 89(4):2542-51.
PMID: 16055534
PMC: 1366753.
DOI: 10.1529/biophysj.104.057109.
Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.
Chillemi G, Redinbo M, Bruselles A, Desideri A
Biophys J. 2004; 87(6):4087-97.
PMID: 15347588
PMC: 1304917.
DOI: 10.1529/biophysj.104.044925.
Protein concerted motions in the DNA-human topoisomerase I complex.
Chillemi G, Fiorani P, Benedetti P, Desideri A
Nucleic Acids Res. 2003; 31(5):1525-35.
PMID: 12595561
PMC: 149835.
DOI: 10.1093/nar/gkg242.
Molecular dynamics simulation of the RNA complex of a double-stranded RNA-binding domain reveals dynamic features of the intermolecular interface and its hydration.
Castrignano T, Chillemi G, Varani G, Desideri A
Biophys J. 2002; 83(6):3542-52.
PMID: 12496121
PMC: 1302429.
DOI: 10.1016/S0006-3495(02)75354-X.